Lawrence E. Flaherty

8.3k citations
100 papers · 6.5k · 1 hit paper · h-index 39

Impact in

  • Oncology top 0.5%
    • Cutaneous Melanoma Detection and Management
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
  • Immunology top 2%
    • Immunotherapy and Immune Responses

Papers in

    • Cutaneous Melanoma Detection and Management 51
    • Cancer Immunotherapy and Biomarkers 9
    • HER2/EGFR in Cancer Research 3
    • Prostate Cancer Treatment and Research 7
    • Renal cell carcinoma treatment 6

Lawrence E. Flaherty

98 papers receiving 6.1k citations

Lawrence E. Flaherty's Hit Papers

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma 2004 · 650 citations
6500+7+14Years since publication200400600

Peers

Lawrence E. Flaherty
Comparison fields: 5 of 104
  • Oncology 3k
  • Immunology 821
  • Pulmonary and Respiratory Medicine 1.3k
  • Cancer Research 318
  • Molecular Biology 1.1k
Replace Anthony J. Olszanski with:
Anthony J. Olszanski United States
Alan Anthoney United Kingdom
Catalin Liviu Dragos Mihalcioiu Canada
Elaine M. Rankin United Kingdom
Micaela Hernberg Finland
Wim H.J. Kruit Netherlands
Aleksandra Szczęsna Poland
Jean-Pascal Machiels Belgium
Vladimir Mikhailovich Moiseyenko Russia
Marilyn L. Slovak United States
Lawrence E. Flaherty relative to Anthony J. Olszanski United States Anthony J. Olszanski's profile →
Citations per field
00.5×1.5×1.8×
Anthony J. Olszanski · 1×
Citations per year

Countries citing papers authored by Lawrence E. Flaherty

Since Specialization
Citations

This map shows the geographic impact of Lawrence E. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Flaherty more than expected).

Fields of papers citing papers by Lawrence E. Flaherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence E. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Flaherty. The network helps show where Lawrence E. Flaherty may publish in the future.

Co-authors

The 25 scholars most cited alongside Lawrence E. Flaherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence E. Flaherty Line = papers co-authored together Lawrence E. Flaherty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000741
2
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
2004650
3 2017469
4 2008253
5 2014227
6 2002186
7 2012180
8 1994179
9 2002166
10 2005164
11 1998148
12 1998144
13 2019144
14 2004139
15 2011137
16 2002130
17 2001123
18 1995105
19 200298
20 199590

About Lawrence E. Flaherty

Lawrence E. Flaherty is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Hematology, having authored 100 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (51 papers), Cancer Immunotherapy and Biomarkers (9 papers), Melanoma and MAPK Pathways (9 papers), Prostate Cancer Treatment and Research (7 papers), Renal cell carcinoma treatment (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer therapeutics and mechanisms (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (3k citations), Immunology (821 citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (318 citations) and Molecular Biology (1.1k citations). Lawrence E. Flaherty has collaborated with scholars based in United States, Hungary and Pakistan. Frequent co-authors include Vernon K. Sondak, John M. Kirkwood, Bruce G. Redman, Jeffrey Alan Sosman, Marc S. Ernstoff, Michael B. Atkins, Jon M. Richards, Joseph M. Unger, Joseph G. Ibrahim and Ehab L. Atallah. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Journal of Immunotherapy and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact